Good question. Last June, the FDA approved the use of a new HPV vaccine to prevent infection from four types of human papillomavirus (HPV). Two of them (targeted by the vaccine) are believed to be behind about 70 percent of the cases of cervical cancer worldwide, according to the National Institutes of Health.
The other two, NIH says, cause bout 90 percent of the cases of genital warts. The vaccine is made by Merck & Co., Inc., and is based on laboratory research and technology developed at the National Cancer Institute (NCI).
A woman needs to get three shots. Once you get the first shot, you need a second shot two months later. You need to get a third shot six months after you get the first shot.
And if you’re in need of more information, the National Institutes of Health has these helpful links:
Comment Reply
Hi Kelley,
Good question. Last June, the FDA approved the use of a new HPV vaccine to prevent infection from four types of human papillomavirus (HPV). Two of them (targeted by the vaccine) are believed to be behind about 70 percent of the cases of cervical cancer worldwide, according to the National Institutes of Health.
The other two, NIH says, cause bout 90 percent of the cases of genital warts. The vaccine is made by Merck & Co., Inc., and is based on laboratory research and technology developed at the National Cancer Institute (NCI).
A woman needs to get three shots. Once you get the first shot, you need a second shot two months later. You need to get a third shot six months after you get the first shot.
And if you’re in need of more information, the National Institutes of Health has these helpful links:
HPV Q & A:
http://www.cancer.gov/cancertopics/factsheet/Risk/HPV
Cancer Vaccine Fact Sheet
http://www.cancer.gov/cancertopics/factsheet/cancervaccine
Cervical Cancer Section
http://www.cancer.gov/cancertopics/types/cervical
You can also call 1-800-4-CANCER or visit their chat line at:
April 3, 2008 - 1:03pmhttps://cissecure.nci.nih.gov/livehelp/welcome.asp
This Comment
Reply